Douglas J. Manion
Pres and CEO at Aclaris Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Aclaris Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 1, 2024 | Aclaris Therapeutics Inc. | Option exercise | +27,000 | — | — |
| Jan 1, 2024 | Aclaris Therapeutics Inc. | Shares withheld for tax | −9,125 | $1.05 | $9,581 |
| Aug 1, 2023 | Aclaris Therapeutics Inc. | Option exercise | +15,575 | — | — |
| Aug 1, 2023 | Aclaris Therapeutics Inc. | Shares withheld for tax | −4,437 | $9.81 | $43,527 |
| Mar 17, 2023 | Aclaris Therapeutics Inc. | Open-market purchase | +6,300 | $7.86 | $49,518 |
| Mar 9, 2023 | Aclaris Therapeutics Inc. | Open-market purchase | +6,500 | $7.74 | $50,310 |
Questions about Douglas J. Manion
What boards is Douglas J. Manion on?
Douglas J. Manion sits on the board of Aclaris Therapeutics Inc.
What company is Douglas J. Manion the CEO of?
Douglas J. Manion is Pres and CEO of Aclaris Therapeutics Inc.
How long has Douglas J. Manion served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.